Bone Marrow-derived Cells' Contribution to Tumor Formation and Inflammation

This study is currently recruiting participants. (see Contacts and Locations)
Verified August 2009 by Komagome Hospital
Sponsor:
Information provided by:
Komagome Hospital
ClinicalTrials.gov Identifier:
NCT00452205
First received: March 26, 2007
Last updated: August 3, 2009
Last verified: August 2009
  Purpose

The purpose of this study is to clarify the relationship bone marrow-derived cells and the formation of the tumors, and the role of these cells in regeneration of epithelial cells in the gastrointestinal tract.


Condition
Gastrointestinal Neoplasms

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Bone Marrow-derived Cells' Contribution to Tumor Formation and Epithelial Cells Regeneration in the Gastrointestinal Tract

Resource links provided by NLM:


Further study details as provided by Komagome Hospital:

Biospecimen Retention:   Samples With DNA

tissue


Estimated Enrollment: 300
Study Start Date: April 2007
Estimated Study Completion Date: March 2017
  Show Detailed Description

  Eligibility

Ages Eligible for Study:   20 Years to 70 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

patients received bone marrow transplantation in Tokyo Metropolitan Komagome Hospital

Criteria

Inclusion Criteria:

  • After allogeneic bone marrow transplantation

Exclusion Criteria:

  • Contraindication for gastrointestinal endoscopy
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00452205

Contacts
Contact: Naoto Egawa, MD +81-3-3823-2101 ext 6158 naoto@cick.jp
Contact: Hisashi Sakamaki, MD +81-3-3823-2101 ext 6153 sakamaki@cick.jp

Locations
Japan
Cancer and Infection Disease Center, Komagome Recruiting
Tokyo, Bunkyo-ku, Japan, 113-8677
Contact: Naoto Egawa, MD    +81-3-3823-2101 ext 6158    naoto@cick.jp   
Contact: Hisashi Sakamaki, MD    +81-3-3823-2101 ext 6153    sakamaki@cick.jp   
Principal Investigator: Naoto Egawa, MD         
Sponsors and Collaborators
Komagome Hospital
Investigators
Study Director: Naoto Egawa, MD
  More Information

Publications:
Responsible Party: Naoto Egawa, Tokyo Metropolitan Komagome Hospital
ClinicalTrials.gov Identifier: NCT00452205     History of Changes
Other Study ID Numbers: CICK-07521
Study First Received: March 26, 2007
Last Updated: August 3, 2009
Health Authority: Japan: Institutional Review Board

Keywords provided by Komagome Hospital:
bone marrow-derived stem cell
bone marrow transplantation
graft versus host disease
gastrointestinal cancer
after receiving bone marrow transplantation

Additional relevant MeSH terms:
Gastrointestinal Neoplasms
Digestive System Neoplasms
Neoplasms by Site
Neoplasms
Digestive System Diseases
Gastrointestinal Diseases

ClinicalTrials.gov processed this record on September 16, 2014